Anti-VEGF medicines for wet age-related macular degeneration (AMD)

References

Citations

  1. Drugs for some common eye disorders (2007). Treatment Guidelines from The Medical Letter, 5(53): 4–5.

  2. Rosenfeld PJ, et al. (2006). Ranibizumab for neovascular age-related macular degeneration. New England Journal of Medicine, 355(14): 1419–1431.


Author: Robin Parks, MSLast Updated: August 13, 2007
Medical Review: Kathleen Romito, MD - Family Medicine
Carol L. Karp, MD - Ophthalmology

© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Click here to learn about Healthwise
Click here to learn about Healthwise
Topic Contents
 Examples
 How It Works
 Why It Is Used
 How Well It Works
 Side Effects
 What To Think About
 References